Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)

In market activity today, Briacell Therapeutics Corp stock opened at $1.26 and closed at $1.20. It traded at a low of $1.18 to a high of $1.26.

Shares dipped -4.00% from the previous day's close of $1.25.

Today across North America, the TSX Composite closed 0.57% at 22673.52, the S&P 500 closed -0.88% at 5584.54, the Dow Jones Industrial Average closed 0.08% at 39753.75 and the Nasdaq Composite closed -1.95% at 18283.41.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

A total of 2,800 shares was traded during the session, with total trades of 24, with an average volume of 7,263 over 5 days.

Trading across the entire TSX saw 3,781 price advancers against 1,454 declines and 97 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $1.18 (July 12,2024). Moreover, the shares have shrunken -85.80 percent in the last 52 weeks, while they have plummeted -84.62% since the start of 2024.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $22.86 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp has an average recommendation of "Strong Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..